Author: Dalmeet Singh Chawla

Despite retraction, antipsychotics still effective, safe for dementia, says author

alzheimers-research-and-therapyResearchers have retracted a systematic review that suggested that antipsychotic drugs are effective and safe for patients with symptoms of dementia — but claim their re-analysis of the updated data still comes to the same conclusions.

According to the retraction notice in Alzheimer’s Research and Therapy, some participants were incorrectly included twice in the meta-analysis. 

The corresponding authors recently lost another paper for an entirely different reason — earlier this year, we reported on a retraction in Annals of Neurology for Jin-Tai Yu and Lan Tan, affiliated with the Ocean University of China, Qingdao University, and Nanjing Medical University in China. The authors pulled that paper after appearing to pass off others’ data as their own.

Here’s the retraction notice for the review, issued earlier this year: Continue reading Despite retraction, antipsychotics still effective, safe for dementia, says author

Authors fix three Diabetes papers flagged for image issues

diabetesResearchers have corrected three studies published in the journal Diabetes after users flagged issues with the images on PubPeer.

All three papers share a number of authors, including the same last and corresponding author, Aimin Xu, from The University of Hong Kong.

Since the corrections appear relatively extensive, we asked the journal if retractions were ever on the table. According to Chris Kohler, associate publisher, scholarly journals at American Diabetes Association, which publishes Diabetes, an ethical panel reviewed the papers before allowing the authors to issue the errata, all of which were published online this month: Continue reading Authors fix three Diabetes papers flagged for image issues

Parkinson’s researcher with three retractions heads to court on Monday

Caroline Barwood
Caroline Barwood

On Monday, Parkinson’s researcher Caroline Barwood will head to court in Brisbane, Australia, following a probe at her former institution, the University of Queensland (UQ).

Barwood was granted bail in November, 2014 — charges included  that she “dishonestly applied for grant funds,” and fabricated research that claimed a breakthrough in treating Parkinson’s disease, according to The Guardian. In March, Bruce Murdoch, a former colleague of Barwood’s at UQ, pleaded guilty to 17 fraud-related charges, and received a two-year suspended sentence after an institutional investigation into 92 academic papers.

We contacted Barwood about the upcoming trial, but she told us Continue reading Parkinson’s researcher with three retractions heads to court on Monday

Authors retract (and replace) cardiac rehab study in JAMA journal

jama-internal-medicine

Researchers have retracted and replaced a 2014 paper in JAMA Internal Medicine after realizing a number of errors had affected the findings.

The authors note the mistakes do not have a significant impact on the overall proportion of heart patients who participated in cardiac rehab. However, a number of findings were affected, such as the difference in participation in cardiac rehab defined by race, and how the overall participation has changed throughout the years.

Therefore, JAMA Internal Medicine has published a lengthy notice of retraction and replacement, which explains the errors made in the original paper, and updated the first paper with a new version of the study.

The retraction and replacement notice, issued this week, starts: Continue reading Authors retract (and replace) cardiac rehab study in JAMA journal

Cancer researcher earns 5th retraction after misconduct finding

oncoimmunologyA cancer researcher has logged her fifth retraction following an investigation that concluded she had committed scientific misconduct.

We’ve previously reported on four retractions of papers by Stephanie Watkins, a researcher at Loyola Medicine. The previously issued notices — in The Journal of Clinical Investigation and Cancer Research — note that an investigation committee appointed by the National Institutes of Health (NIH) found Watkins to be solely responsible for the misconduct, with none of the co-authors aware of it.

The editor of OncoImmunology previously informed us that the journal was investigating another one of Watkins’ papers; the journal has now pulled that paper, citing “fabrication and falsification of data” in the original studies referenced in the paper.

Here’s the retraction notice, published online earlier this year: Continue reading Cancer researcher earns 5th retraction after misconduct finding

Cardiovascular researcher in Taiwan logs four retractions

clinical-scienceA researcher has earned four retractions following an investigation at his institutions in Taiwan.

The retraction notices, which appear in Clinical Science, mention investigations into the work of Kou-Gi Shyu at the Shin-Kong Wu Ho-Su Memorial Hospital and Taipei Medical University (TMU).

Shyu is listed as being affiliated with both institutions in the original papers, but a TMU official told us Shyu left his teaching role at TMU amidst the probe. Shyr-Yi Lin, professor of medicine and dean of research and development at TMU, noted: Continue reading Cardiovascular researcher in Taiwan logs four retractions

Cancer biologist says Nature journal “censored” his News & Views, retracts it

nature-reviews-clinical-oncologyA cancer biologist has retracted a 2016 News & Views article in a Nature journal, alleging that the journal tried to censor his writing by asking him to remove passages that criticized another journal (Cell). 

Carlo Croce, the sole author of the article in Nature Reviews Clinical Oncology from Ohio State University in Columbus, described the journal’s actions to us as “disgusting” and “worrisome.”

A spokesperson from the journal sent us this statement:

We regret that this situation occurred. We cannot comment beyond the retraction notice.

This isn’t Croce’s first retraction (we just found another recent one, in the Journal of Biological Chemistry, over image problems). He’s also co-authored multiple papers with Alfredo Fusco, a cancer researcher in Italy who has nine retractions under his belt, and is undergoing criminal investigation for scientific misconduct.

Here’s the retraction notice, published in Nature Reviews Clinical Oncology on October 4: Continue reading Cancer biologist says Nature journal “censored” his News & Views, retracts it

Texas participant in physics breakthrough repaid $5M in misspent funds

utrgvThe Texas institute that participated in the groundbreaking gravitational waves discovery had to repay nearly $5 million in funding after misusing and misreporting benefits, according to audits obtained by The Monitor.

The infractions occurred at The University of Texas Brownsville, which has since become part of The University of Texas Rio Grande Valley (UTRGV). Once the issues were discovered, UTRGV had to make the reimbursements.

As The Monitor reported: Continue reading Texas participant in physics breakthrough repaid $5M in misspent funds

Journal flags paper at center of authorship dispute

carbohydrate-polymersA journal has issued an expression of concern (EOC) for a nanofilm paper after a researcher protested being left off the author list. 

According to the notice in Carbohydrate Polymers, the University of Calcutta in West Bengal, India, where the research was carried out, has “failed to provide evidence of a thorough, fair, and proper investigation of this claim,” despite being presented with evidence from both sides.

The study’s last and corresponding author told us that his former student, who had previously co-authored some abstracts, got in touch with journal, alleging to be an author of the present paper. 

Here’s the EOC for “Cationic guar gum orchestrated environmental synthesis for silver nano-bio-composite films:” Continue reading Journal flags paper at center of authorship dispute

Child psychiatrist flagged for misconduct loses two more papers

Mani PavuluriA child psychiatrist has lost two papers after an institutional investigation concluded that she intentionally misrepresented children’s medication history in her research.

In November 2015, we reported on a retraction for Mani Pavuluri in the Journal of Psychiatry & Neuroscience following a probe at the University of Illinois at Chicago, her institution, which concluded that there was a “preponderance of evidence” that Pavuluri had committed misconduct. 

After an “unanticipated event” took place during a study, three studies by Pavuluri were halted and a letter was sent out to 350 research subjects, informing them of errors in the work. At the time, the Illinois spokesperson noted that Pavuluri — who, according to her LinkedIn page, is a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry — was also asked to retract two 2013 studies in the Journal of Affective Disorders. Those papers have now been retracted, noting that Pavuluri “intentionally and knowingly” misrepresented children’s medication history.

Here’s the retraction notice for “Deficits in emotion recognition in pediatric bipolar disorder: The mediating effects of irritability:” Continue reading Child psychiatrist flagged for misconduct loses two more papers